Verdad Advisers »

Tenax Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Tenax Therapeutics (TENX) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Tenax Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenax Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenax Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 95k 15.99

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Tenax Therapeutics

Henderson Group
VR Adviser
Perceptive Advisors
Ikarian Capital
Stonepine Capital Management
Logos Global Management
Morgan Stanley
Adage Capital Partners GP
Point72 Asset Management
Millennium Management
Armistice Capital
Siren
Boothbay Fund Management
TD Asset Management
UBS Group

View all funds holding Tenax Therapeutics